Information Journal Paper
APA:
CopyTJAN HEIJNEN, V.C., POSTMUS, P.E., & ARDIZZONI, A.. (2001). REDUCTION OF CHEMOTHERAPY-INDUCED FEBRILE LEUCOPENIA BY PROPHYLACTIC USE OF CIPROFLOXACIN AND ROXITHROMYCIN IN SMALL-CELL LUNG CANCER PATIENTS: AN EORTC DOUBLE-BLIND PLACEBO-CONTROLLED PHASE III STUDY. ANNALS OF ONCOLOGY (OFFICIAL JOURNAL OF THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY: ESMO), 12(-), 1359-1368. SID. https://sid.ir/paper/659472/en
Vancouver:
CopyTJAN HEIJNEN V.C., POSTMUS P.E., ARDIZZONI A.. REDUCTION OF CHEMOTHERAPY-INDUCED FEBRILE LEUCOPENIA BY PROPHYLACTIC USE OF CIPROFLOXACIN AND ROXITHROMYCIN IN SMALL-CELL LUNG CANCER PATIENTS: AN EORTC DOUBLE-BLIND PLACEBO-CONTROLLED PHASE III STUDY. ANNALS OF ONCOLOGY (OFFICIAL JOURNAL OF THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY: ESMO)[Internet]. 2001;12(-):1359-1368. Available from: https://sid.ir/paper/659472/en
IEEE:
CopyV.C. TJAN HEIJNEN, P.E. POSTMUS, and A. ARDIZZONI, “REDUCTION OF CHEMOTHERAPY-INDUCED FEBRILE LEUCOPENIA BY PROPHYLACTIC USE OF CIPROFLOXACIN AND ROXITHROMYCIN IN SMALL-CELL LUNG CANCER PATIENTS: AN EORTC DOUBLE-BLIND PLACEBO-CONTROLLED PHASE III STUDY,” ANNALS OF ONCOLOGY (OFFICIAL JOURNAL OF THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY: ESMO), vol. 12, no. -, pp. 1359–1368, 2001, [Online]. Available: https://sid.ir/paper/659472/en